BMP Pharma Trading AG
XBER:BMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shaanxi Zhongtian Rocket Techonology Co Ltd
SZSE:003009
|
CN |
|
HEBA Fastighets AB
STO:HEBA B
|
SE |
BMP Pharma Trading AG
Other Current Liabilities
BMP Pharma Trading AG
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
BMP Pharma Trading AG
XBER:BMP
|
Other Current Liabilities
€10k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-16%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Other Current Liabilities
€52.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Bayer AG
XETRA:BAYN
|
Other Current Liabilities
€18.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
|
Merck KGaA
XETRA:MRK
|
Other Current Liabilities
€5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Biotest AG
XETRA:BIO
|
Other Current Liabilities
€47.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-4%
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Other Current Liabilities
€117.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
BMP Pharma Trading AG
Glance View
B.M.P.Pharma Trading AG engages in the selling and distribution of pharmaceutical raw materials, dietary supplement products and raw materials of the veterinary industry. The company is headquartered in Norderstedt, Schleswig-Holstein. The company went IPO on 2004-04-21. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.
See Also
What is BMP Pharma Trading AG's Other Current Liabilities?
Other Current Liabilities
10k
EUR
Based on the financial report for Dec 31, 2024, BMP Pharma Trading AG's Other Current Liabilities amounts to 10k EUR.
What is BMP Pharma Trading AG's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-16%
Over the last year, the Other Current Liabilities growth was -50%. The average annual Other Current Liabilities growth rates for BMP Pharma Trading AG have been -11% over the past three years , -48% over the past five years , and -16% over the past ten years .
